Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase
- 26 May 1994
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (14), D3-D11
- https://doi.org/10.1016/0002-9149(94)90626-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemiaThe American Journal of Cardiology, 1993
- Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performanceClinical Cardiology, 1992
- Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in HumansThe Journal of Clinical Pharmacology, 1992
- Single‐Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal ImpairmentThe Journal of Clinical Pharmacology, 1992
- Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and LovastatinThe Journal of Clinical Pharmacology, 1990
- Clinical experience with lovastatinThe American Journal of Cardiology, 1990
- Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoBiochemical and Biophysical Research Communications, 1989
- Preclinical evaluation of lovastatinThe American Journal of Cardiology, 1988
- More on Rifampin Prophylaxis againstHaemophilus influenzaeb in Day-Care FacilitiesNew England Journal of Medicine, 1988
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986